EDUCATING LEADERS IN PHARMACY AND PHARMACEUTICAL SCIENCES SINCE 1886
Buffalo Pharmacy a formidable presence at ASHP Midyear Clinical Meeting and Exhibition
L-R: Dr. Tammie Lee Demler, Dr. Nicole Albanese, Dr. Charisse Chehovich, Dr. Hailey Lipinski, Dr. Courtney Cardinal and Dr. Erin Slazak at the Residency Showcase
By Kara Sweet
Published December 5, 2018 This content is archived.
The University at Buffalo School of Pharmacy and Pharmaceutical Sciences had an impressive number of faculty, students and residents present at the 2018 American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting and Exhibition in Anaheim, CA.
The school also hosted a reception for students, staff, alumni and friends, which offered reconnection and networking opportunities.
ASHP’s Midyear Clinical Meeting and Exhibition is the largest gathering of pharmacy professionals in the world. Attended by more than 25,000 pharmacy professionals from all over the globe, the Midyear Clinical Meeting provides valuable opportunities for professional development, networking, enhancing practice skills, and staying current with the latest products and innovations.
Faculty
Calvin Meaney, PharmD ’11, clinical assistant professor, pharmacy practice, gave a continuing education presentation entitled “Insights into anemia management in chronic kidney disease: New discoveries, strategies, and models of care.”
Participating in the popular Residency Showcase were UB SPPS residency directors Erin Slazak, PharmD ’04, clinical assistant professor, pharmacy practice, Nicole Albanese, clinical associate professor, pharmacy practice, and Tammie Lee Demler, adjunct instructor, pharmacy practice.
Residents
Charisse Chehovich, Courtney Cardinal and Hailey Lipinski
Courtney Cardinal, PharmD ’17, PGY2 Ambulatory Care, General Physician, PC
Outcomes of a pharmacist-driven transitions-of-care program within a patient-centered medical home
Charisse Chehovich, PharmD ’18, PGY1 Pharmacy, Buffalo Psychiatric Center
Exploring lithium serum concentrations and their role in the increasing polypharmacy trend
Hailey Lipinski, PGY2 Ambulatory Care, Buffalo Medical Group
Adherence to updated metformin dosing recommendations in a patient-centered medical home: a comparison of provider-pharmacist team versus provider-only approaches
Scholars Program Students
Mary Hejna, PharmD ‘20
Preliminary review of the literature to develop a medication fall risk assessment tool
Jennifer Aguilar, PharmD ‘19
Vancomycin versus linezolid for the treatment of acute pulmonary exacerbations of cystic fibrosis
Lukas Brightman, PharmD ‘19
Assessment of induced hypertension following acute ischemic stroke
Chung Chen, PharmD ‘19
Management of Laparoscopic sleeve gastrectomy candidates with type 2 diabetes mellitus (T2DM): impact of a pre-treatment algorithm
Christy Cheruvil, PharmD ‘19
Hypoalbuminemia and bleeding events in patients treated with rivaroxaban
Melissa McGowan, PharmD ‘19
Acute kidney injury associated with vancomycin in combination with piperacillin/tazobactam, cefepime, or meropenem in critically ill patients: a drug-shortage driven quasi-experimental study
Merin Panthapattu, PharmD ‘19
Evaluation of a pharmacist-led transitions of care pilot program in a primary care practice
Rachel Klosko, PharmD ‘19
Lifetime weight trajectory, weight triggers and their association to successful weight loss after bariatric surgery
Clinical Research Program Students
Amy Drzewiecki, PharmD ‘19
Utilization of newer branded diabetes products in the New York State Medicaid program
Yoscar Ogando, PharmD ‘19
Reticulocyte indices to better inform hemoglobin response of Erythropoiesis Stimulating Agents in Hemodialysis: Hitting the Hemoglobin Bull’s-eye
Gigi Yam, PharmD ‘19
Polypharmacy in aging human immunodeficiency virus (HIV) positive adults: a retrospective drug utilization study
Stacie Yi, PharmD ‘19
Outcomes of Staphylococcus aureus infections in critically ill children: do vancomycin trough concentrations matter?
Abby Fornes, PharmD ‘19
Response: Weight triggers and their association to successful weight loss after bariatric surgery
Jessica Greger, PharmD ‘19
Comparison of stroke outcomes: does pharmacist intervention and platelet aggregation testing make a difference?
PharmD Students
Colleen McKinney, PharmD ‘19
Severity of acute kidney injury with vancomycin in combination with piperacillin/tazobactam, meropenem, or cefepime
Sneha Monzy, PharmD ‘19
Prescriber-selected indications for inpatient pediatric antibiotic therapy in a computerized physician order entry system
Deon Edionwe, PharmD ‘19
Characterization and factors influencing medication treatment concordance with heart failure guidelines in patients admitted for heart failure to a Hospice Program
Donald Singh, PharmD ‘19
Assessment of the use of a nurse-driven hypoglycemia management protocol at a tertiary care medical center
Patrick McGrath, PharmD ‘19
Systematic review of viral polymerase complex inhibitors for the treatment of influenza
For over 130 years, the University at Buffalo School of Pharmacy and Pharmaceutical Sciences has continually been a leader in the education of pharmacists and pharmaceutical scientists, renowned for innovation in clinical practice and research. The school is accredited by the American Council of Pharmaceutical Education (ACPE) and is the No. 1 ranked school of pharmacy in New York State and No. 22 in the United States by U.S. News & World Report.